Navigation Links
Burroughs Wellcome Fund grants $9.75 million towards translational researchers
Date:3/7/2008

y of Michigan-Ann Arbor
Viral mechanisms of persistence in HIV infected people

Laurence Cooper, M.D., Ph.D.
University of Texas M.D. Anderson Cancer Center
Tumor-specific alloantigen-anergic donor-derived T-cell therapy after hematopoietic stem cell transplantation

William M. Grady, M.D.
University of Washington
Novel biomarkers for the prevention and treatment of colon cancer

S. Ananth Karumanchi, M.D.
Harvard Medical School
Soluble endoglin in the pathogenesis and prediction of preclampsia

Frances Lee, M.D., Ph.D.
Weill Medical College of Cornell University
Role of BDNF in therapeutic strategies for affective disorders

Ernst R. Lengyel, M.D., Ph.D.
University of Chicago
Development of novel therapeutic and diagnostic strategies for ovarian cancer

Daniel L. Marks, M.D., Ph.D.
Oregon Health and Science University
Maternal nutrition and fetal metabolic programming

Jonathan R. Pollack, M.D., Ph.D.
Stanford University
Pathogenesis and diagnosis of clinically-indolent prostate cancer

Theodora S. Ross, M.D., Ph.D.
University of Michigan-Ann Arbor
Abnormal HIP1 and cancer biology

Jeffrey A. Toretsky, M.D.
Georgetown University Lombardi Comprehensive Cancer Center
Novel cancer therapeutics based upon oncogenic fusion-protein transcription factors

Edus H. Warren, M.D., Ph.D.
University of Washington
Toward immune therapy for colon cancer: identification of antigens recognized by CD8+ T lymphocytes on colon cancer stem cells

Kang Zhang, M.D., Ph.D.
University of Utah
Define novel genes for diabetic microvascular complications


'/>"/>

Contact: Russ Campbell
news@bwfund.org
919-991-5119
Burroughs Wellcome Fund
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... promote Massachusetts companies through annual marketing campaign , ... ... BioSpace unveiled the 2010 Genetown™ Hotbed Campaign as ... , ,Genetown is sponsored by MassBio and showcases ... The campaign places each entity’s brand on an electronic ...
(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced Alison Davies as ... Ms. Davies has spent the last fourteen ... industry, most recently for nine years as a ... of Invisalign . ,, (Logo: ...
(Date:12/16/2009)... 16 In a random sampling of ... ME, and Philadelphia, PA, numerous pallets tested positive ... that could potentially create health hazards for consumers. ... previous wood pallet testing conducted in the Washington-Baltimore ... risks to our nation,s food supply from wood ...
(Date:12/16/2009)... in methionine, an amino acid typically found in ... yogurt and seeds, can possibly increase the risk ... by Temple researchers. , The researchers published their ... deposition in a mouse model of Alzheimer,s disease," ... , "When methionine reaches too high a level, ...
(Date:12/16/2009)... program ,, SCHAUMBURG, Ill., Dec. 16 ... deadliest form of skin cancer, almost every hour. ... early. That,s why thousands of dermatologists across the ... communities through the American Academy of Dermatology,s (AAD) ... reached a milestone - two million screenings have ...
Breaking Medicine News(10 mins):Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 3Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 4Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3
... Dr. Philip James, the British chairman of the International ... responsible //for the obesity epidemic in poor countries. ... are those which subsidize and distort the market to ... more expensive," James said at the 10th International Obesity ...
... officials in Northern Ireland are about to launch ... a deadly form of meningitis. //The vaccination against ... childhood immunization programme. ,"Pneumococcal meningitis is ... Research Foundation, said. "Children can effectively die or ...
... researchers have developed a thirst sensor designed to alert the ... avoid dehydration.// ,The device evaluates the relationship between bodily ... body has too little water. ,Four tiny contact ... relaying it to a pocketbook-sized apparatus carried next to the ...
... has reported that its experimental vaccine against a virus ... in the number// of cases and deaths from the ... Cervarix prevents the infection from two strains of the ... percent of cases of cervical cancer. ,At a ...
... tissue suppliers’ scandals, the patients who received tendons, cartilage and ... tests for hepatitis and HIV. This is happening for the ... officials won’t tell the number of people, across the country, ... is difficult to tell about the risk recipients face. ...
... addition to overall research infrastructure upgradation, there are strategies ... for ageing at the Madras Medical College (MMC). ... discussion between an MMC team and Director General N. ... for Medical Research. This was followed by the inauguration ...
Other Medicine News:Health News:Tissue implant scandal heightens FDA’s concer 2Health News:Madras Medical College to have a Centre for preventive cardiology 2
(Date:12/16/2009)... Greenway Medical Technologies, Inc. today announced ... (EHR), practice management and interoperability solution, Prime Suite® ... in the annual 2009 Top 20 Best ... report. ,, For practices having between six ... named Best in KLAS in ambulatory EMR for ...
(Date:12/16/2009)... AMSTERDAM, December 16 Today, Avantium ... Executive Officer of its pharmaceutical,business. Gunnar Staaf ... and Eli Lilly & Company, in a ... is an important step in Avantium,s plan ... to create a,stand-alone pharmaceutical company based on ...
(Date:12/16/2009)... and MinuteClinic health care centers located in select ... 20 states and Washington, D.C. While in ... continue, many states have lifted restrictions, allowing all ... while supplies last. In addition, seasonal influenza ... MinuteClinic locations across the country on demand seven ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Avantium Appoints Gunnar Staaf as CEO Pharma 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 1Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 2Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 3Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 4Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 5Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 6Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results 6321 7Acute Ischemic Stroke Drug Market Will Remain Relatively Flat Increasing From 24360 Million in 2008 to 24450 Million in 2018 6319 1Acute Ischemic Stroke Drug Market Will Remain Relatively Flat Increasing From 24360 Million in 2008 to 24450 Million in 2018 6319 2FDA Grants GeoVax Labs Inc Request For Pre IND Meeting 6317 1FDA Grants GeoVax Labs Inc Request For Pre IND Meeting 6317 2FDA Grants GeoVax Labs Inc Request For Pre IND Meeting 6317 3FDA Grants GeoVax Labs Inc Request For Pre IND Meeting 6317 4
... Sub-study Part of the Cardiovascular, Research Foundation,s ADAPT-DES Study to Quantify ... ... DIEGO, Oct. 22 Volcano Corporation,(Nasdaq: VOLC ) [TCT Booth ... measurement (FM) technology,announced today its sponsorship of the first major study ...
... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... and,hepatitis C virus (HCV) infection, today announced that ... the Ministry of Health of the Republic of,Georgia ... drug,docetaxel in patients with metastatic breast cancer. The ...
Other Medicine Technology:Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4